277 related articles for article (PubMed ID: 29203479)
61. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH
J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187
[TBL] [Abstract][Full Text] [Related]
62. Integration of DPC and clinical microbiological data in Japan reveals importance of confirming a negative follow-up blood culture in patients with MRSA bacteremia.
Miyamoto N; Yahara K; Horita R; Yano T; Tashiro N; Morii D; Tsutsui A; Yaita K; Shibayama K; Watanabe H
J Infect Chemother; 2017 Oct; 23(10):687-691. PubMed ID: 28818549
[TBL] [Abstract][Full Text] [Related]
63. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
64. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
[TBL] [Abstract][Full Text] [Related]
65. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
Shurland S; Zhan M; Bradham DD; Roghmann MC
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
[TBL] [Abstract][Full Text] [Related]
66. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
67. Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil.
Riche CVW; Cassol R; Falci DR; Ramirez M; Dias CAG
PLoS One; 2023; 18(4):e0283774. PubMed ID: 37053222
[TBL] [Abstract][Full Text] [Related]
68. Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials.
Hos NJ; Jazmati N; Stefanik D; Hellmich M; AlSael H; Kern WV; Rieg S; Wisplinghoff H; Seifert H; Kaasch AJ
J Infect; 2017 Mar; 74(3):248-259. PubMed ID: 28017826
[TBL] [Abstract][Full Text] [Related]
69. Clinical features and risk factors of mortality for bacteremia due to community-onset healthcare-associated methicillin-resistant S. aureus.
Lee SC; Lee CW; Shih HJ; Chiou MJ; See LC; Siu LK
Diagn Microbiol Infect Dis; 2013 May; 76(1):86-92. PubMed ID: 23420009
[TBL] [Abstract][Full Text] [Related]
70. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
[TBL] [Abstract][Full Text] [Related]
71. Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .
Lodise TP; Drusano GL; Lazariu V; El-Fawal N; Evans A; Graffunder E; Stellrecht K; Mendes RE; Jones RN; Cosler L; McNutt LA
J Antimicrob Chemother; 2014 Sep; 69(9):2547-55. PubMed ID: 24840624
[TBL] [Abstract][Full Text] [Related]
72. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
[TBL] [Abstract][Full Text] [Related]
74. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.
Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC
J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999
[TBL] [Abstract][Full Text] [Related]
75. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.
Minejima E; Bensman J; She RC; Mack WJ; Tuan Tran M; Ny P; Lou M; Yamaki J; Nieberg P; Ho J; Wong-Beringer A
Crit Care Med; 2016 Apr; 44(4):671-9. PubMed ID: 26540400
[TBL] [Abstract][Full Text] [Related]
76. Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
Kourtis AP; Hatfield K; Baggs J; Mu Y; See I; Epson E; Nadle J; Kainer MA; Dumyati G; Petit S; Ray SM; ; Ham D; Capers C; Ewing H; Coffin N; McDonald LC; Jernigan J; Cardo D
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(9):214-219. PubMed ID: 30845118
[TBL] [Abstract][Full Text] [Related]
77. Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA infection.
Porto JP; Santos RO; Gontijo Filho PP; Ribas RM
Rev Soc Bras Med Trop; 2013; 46(6):713-8. PubMed ID: 24474012
[TBL] [Abstract][Full Text] [Related]
78. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
[TBL] [Abstract][Full Text] [Related]
79. Mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: a multicenter cohort study in Colombia.
Castillo JS; Leal AL; Cortes JA; Alvarez CA; Sanchez R; Buitrago G; Barrero LI; Gonzalez AL; Henriquez DH;
Rev Panam Salud Publica; 2012 Nov; 32(5):343-50. PubMed ID: 23338691
[TBL] [Abstract][Full Text] [Related]
80. Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.
Calderwood MS; Desjardins CA; Sakoulas G; Nicol R; Dubois A; Delaney ML; Kleinman K; Cosimi LA; Feldgarden M; Onderdonk AB; Birren BW; Platt R; Huang SS;
J Infect Dis; 2014 Feb; 209(4):571-7. PubMed ID: 24041793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
